Overdiagnosis of pulmonary embolism: Definition, causes and implications

Breathe

Volumn 15, Issue 1, 2019, Pages 46-53

  Dobler, Claudia C ^a,b  

^a MAYO CLINIC   (United States)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; APIXABAN; D DIMER; HEPARIN; RIVAROXABAN;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; ARTERIAL OXYGEN SATURATION; CANCER SCREENING; CASE FATALITY RATE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL RISK SCORE; COMPUTER ASSISTED TOMOGRAPHY; DELAYED DIAGNOSIS; DIAGNOSTIC PROCEDURE; FALSE POSITIVE RESULT; FATALITY; HEART RATE; HUMAN; INCIDENTAL FINDING; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG HEMORRHAGE; MORTALITY; OVERDIAGNOSIS; PNEUMONIA; PREDICTIVE VALUE; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOEMBOLISM;

EID: 85065842911     PISSN: 18106838     EISSN: 20734735     Source Type: Journal    
DOI: 10.1183/20734735.0339-2018     Document Type: Review

References (47)

1. Arya R. Venous Thromboembolism Prevention: A Patient Safety Priority. London, Department of Health, 2009. Available from: www.kingsthrombosiscentre.org.uk/kings/12.pdf
2. Office of the Surgeon General, National Heart, Lung, and Blood Institute. The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville, Office of the Surgeon General, 2008.
3. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83: 416–420.
4. van Belle A, Büller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295: 172–179.
5. Gibson NS, Sohne M, Kruip MJ, et al. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb Haemost 2008; 99: 229–234.
6. Freund Y, Cachanado M, Aubry A, et al. Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients: the PROPER randomized clinical trial. JAMA 2018; 319: 559–566.
7. Perera M, Aggarwal L, Scott IA, et al. Underuse of risk assessment and overuse of computed tomography pulmonary angiography in patients with suspected pulmonary thromboembolism. Intern Med J 2017; 47: 1154–1160.
8. Osman M, Subedi SK, Ahmed A, et al. Computed tomography pulmonary angiography is overused to diagnose pulmonary embolism in the emergency department of academic community hospital. J Community Hosp Intern Med Perspect 2018; 8: 6–10.
9. Perelas A, Dimou A, Saenz A, et al. CT pulmonary angiography utilization in the emergency department: diagnostic yield and adherence to current guidelines. Am J Med Qual 2015; 30: 571–577.
10. Crichlow A, Cuker A, Mills AM. Overuse of computed tomography pulmonary angiography in the evaluation of patients with suspected pulmonary embolism in the emergency department. Acad Emerg Med 2012; 19: 1219–1226.
11. Booker MT, Johnson JO. Optimizing CT pulmonary angiogram utilization in a community emergency department: a pre-and postintervention study. J Am Coll Radiol 2017; 14: 65–71.
12. Wiener RS, Ouellette DR, Diamond E, et al. An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine. Chest 2014; 145: 1383–1391.
13. Chopra N, Doddamreddy P, Grewal H, et al. An elevated D-dimer value: a burden on our patients and hospitals. Int J Gen Med 2012; 5: 87–92.
14. Deblois S, Chartrand-Lefebvre C, Toporowicz K, et al. Interventions to reduce the overuse of imaging for pulmonary embolism: a systematic review. J Hosp Med 2018; 13: 52–61.
15. Anjum O, Bleeker H, Ohle R. Computed tomography for suspected pulmonary embolism results in a large number of non-significant incidental findings and follow-up investigations. Emerg Radiol 2019: 26: 29–35.
16. Schiff GD, Hasan O, Kim S, et al. Diagnostic error in medicine: analysis of 583 physician-reported errors. Arch Intern Med 2009; 169: 1881–1887.
17. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756–764.
18. Levinson W, Kallewaard M, Bhatia RS, et al. “Choosing Wisely”: a growing international campaign. BMJ Qual Saf 2015; 24: 167–174.
19. Carter SM, Rogers W, Heath I, et al. The challenge of overdiagnosis begins with its definition. BMJ 2015; 350: h869.
20. Wiener RS, Schwartz LM, Woloshin S. When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ 2013; 347: f3368.
21. Sasahara AA, Stein M, Simon M, et al. Pulmonary angiography in the diagnosis of thromboembolic disease. N Engl J Med 1964; 270: 1075–1081.
22. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 2753–2759.
23. Jha S. The road to overdiagnosis: the case of subsegmental pulmonary embolism. Acad Radiol 2015; 22: 985–987.
24. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 2011; 171: 831–837.
25. Burge AJ, Freeman KD, Klapper PJ, et al. Increased diagnosis of pulmonary embolism without a corresponding decline in mortality during the CT era. Clin Radiol 2008; 63: 381–386.
26. Anderson DR, Kahn SR, Rodger MA, et al. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. JAMA 2007; 298: 2743–2753.
27. Carrier M, Righini M, Wells PS, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost 2010; 8: 1716–1722.
28. Smith-Bindman R, Miglioretti DL, Larson EB. Rising use of diagnostic medical imaging in a large integrated health system. Health Aff 2008; 27: 1491–1502.
29. Ritchie G, McGurk S, McCreath C, et al. Prospective evaluation of unsuspected pulmonary embolism on contrast enhanced multidetector CT (MDCT) scanning. Thorax 2007; 62: 536–540.
30. Schultz DJ, Brasel KJ, Washington L, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J Trauma 2004; 56: 727–731.
31. Klok FA, Huisman MV. Management of incidental pulmonary embolism. Eur Respir J 2017; 49: 1700275.
32. den Exter PL, van der Hulle T, Hartmann IJ, et al. Reliability of diagnosing incidental pulmonary embolism in cancer patients. Thromb Res 2015; 136: 531–534.
33. O’Connell C, Razavi P, Ghalichi M, et al. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. J Thromb Haemost 2011; 9: 305–311.
34. O’Connell CL, Boswell WD, Duddalwar V, et al. Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. J Clin Oncol 2006; 24: 4928–4932.
35. van der Hulle T, den Exter PL, Planquette B, et al. Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients. J Thromb Haemost 2016; 14: 105–113.
36. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149: 315–352.
37. Lyman GH, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31: 2189–2204.
38. Yoo HH, Queluz TH, El Dib R. Anticoagulant treatment for subsegmental pulmonary embolism. Cochrane Database Syst Rev 2014; 4: CD010222.
39. Donato AA, Khoche S, Santora J, et al. Clinical outcomes in patients with isolated subsegmental pulmonary emboli diagnosed by multidetector CT pulmonary angiography. Thromb Res 2010; 126: e266–e270.
40. Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013; 369: 799–808.
41. Büller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012; 366: 1287–1297.
42. Heit JA, Lahr BD, Petterson TM, et al. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood 2011; 118: 4992–4999.
43. Prologo JD, Gilkeson RC, Diaz M, et al. The effect of single-detector CT versus MDCT on clinical outcomes in patients with suspected acute pulmonary embolism and negative results on CT pulmonary angiography. AJR Am J Roentgenol 2005; 184: 1231–1235.
44. Stein PD, Goodman LR, Hull RD, et al. Diagnosis and management of isolated subsegmental pulmonary embolism: review and assessment of the options. Clin Appl Thromb Hemost 2012; 18: 20–26.
45. Goodman LR. Small pulmonary emboli: what do we know? Radiology 2005; 234: 654–658.
46. Dobler CC, Midthun DE, Montori VM. Quality of shared decision making in lung cancer screening: the right process, with the right partners, at the right time and place. Mayo Clin Proc 2017; 92: 1612–1616.
47. Dobler CC, Harb N, Maguire CA, et al. Treatment burden should be included in clinical practice guidelines. BMJ 2018; 363: k4065.